Guardant Health Inc
NASDAQ:GH 4:00:00 PM EDT
| Market Cap (Intraday) | 6.60B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $50.36 |
| 50-Day MA | $45.24 |
| 200-Day MA | $37.56 |
Guardant Health Inc Stock, NASDAQ:GH
3100 Hanover Street, Palo Alto, California 94304
United States of America
Phone: +1.855.698.8887
Number of Employees: 2021
Description
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.